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During the first countrywide outbreak of dengue hemorrhagic
fever in Bangladesh, we conducted surveillance for dengue at
a hospital in Dhaka. Of 176 patients, primarily adults, found
positive for dengue, 60.2% had dengue fever, 39.2% dengue
hemorrhagic fever, and 0.6% dengue shock syndrome. The
Dengue virus 3 serotype was detected in eight patients.
engue fever (DF) and dengue hemorrhagic fever (DHF)
are caused by four antigenically distinct but related den-
gue virus (official name: Dengue virus [DENV]) serotypes
transmitted primarily by Aedes aegypti (yellow fever mos-
quito). DHF, the severe form of the disease, is endemic and
frequently intensifies into epidemics in Southeast Asia, result-
ing in frequent hospitalizations and deaths (1,2). Recently,
dengue has emerged as a substantial global health problem
with increased incidence in new countries and tropical areas
(3,4). DF was documented in Bangladesh from the mid-1960s
to the mid-1990s, but an outbreak of DHF has not been previ-
ously reported (5,6). During late June 2000, a 28-year-old
patient was admitted to a hospital in Dhaka, Bangladesh, with
hemorrhagic fever, ascites, pleural effusion, and thrombocy-
topenia. An enzyme-linked immunosorbent assay (ELISA) for
anti-dengue antibodies confirmed the case as DHF (1). That
summer, an outbreak of DF (>5,000 hospitalized cases
reported) and DHF occurred in Dhaka and other major cities of
Bangladesh (7). 
The Study
We began surveillance for dengue among patients at a hos-
pital in Dhaka during July 1–October 31, 2000. Clinical details
of each patient were recorded on a standardized form; when
indicated, chest radiographs and abdominal ultrasounds were
done, in addition to hemoglobin, hematocrit, and total blood
and platelet counts. Sera from all patients were tested by
ELISA for anti-dengue and anti-Japanese encephalitis viral
immunoglobulin (Ig)M and IgG (8). Paired sera were tested
when available. Sera from 30 patients with fever of <6 days’
duration were also tested for serotype-specific dengue viral
RNA by reverse transcription-polymerase chain reaction (RT-
PCR) (9). Samples having >40 units of IgM or IgG antibodies
were considered positive for dengue infection. A ration of IgM
and IgG <1.8 defined a secondary infection and >1.8 a primary
infection (8). DF, DHF, and dengue shock syndrome (DSS)
were defined according to World Health Organization (WHO)
criteria (1) and confirmed by positive IgM or IgG ELISA or
RT-PCR. Statistical analysis was done by chi-square test.
Of 336 suspected dengue patients, sera were available for
240 patients; 176 (73.3%) had confirmed dengue infection
(168 by ELISA; 2 by RT-PCR; and 6 by both tests). RT-PCR
detected dengue virus 3 serotype (DENV-3) in 8 (26.6%) of 30
patients tested. Both acute- and convalescent-phase sera were
positive in 18 of 30 paired specimens available, and serocon-
version occurred in 2 of the remaining 12 sera. All sera were
negative for antibodies to Japanese encephalitis virus. Thirty-
one (18%) cases were in children (<18 years of age). The high-
est proportion of cases occurred in persons 18–33 years of age
(Figure). DF occurred most commonly (60.2%), followed by
DHF (39.2%), and DSS (0.6%). Most (80%) patients reported
to the hospital after 5 days of fever. Spontaneous bleeding
occurred in 91% of patients with DHF, compared with 25%
patients with DF (p<0.01). Frequent clinical features were
fever (100%), headache (91%), myalgia/arthralgia (85%),
vomiting (64%), macular rash (55%), bleeding (46%) (includ-
ing melena [20%] and bleeding gums [11.6%]), thrombocy-
topenia (<100,000/mL, 56.7%), pleural effusion (12%), ascites
(9%), and hepatomegaly (7.5%). Secondary infection was
detected in 71% of 174 ELISA-positive cases, more com-
monly in patients with DHF than with DF (relative risk 2.14,
p=0.002) (Table). 
All but two adult patients recovered (case-fatality rate
1.14%). One DF patient died with severe hematemesis and
melena; another DSS patient died within 2 hours of hospital-
ization. 
Conclusions
Dengue causes more illness and death than any other arbo-
viral infection in the world (4). This first outbreak highlights
the geographic expansion of DHF in Bangladesh, where clas-
sic DF caused by multiple serotypes had been previously
reported (5,6). The DHF outbreak started in late June 2000,
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peaked in September (during the rainy season), and subsided
in the dry winter season in December 2000. While dengue
affected all age groups, adults predominated in this hospital-
monitored study. In Singapore, India, Malaysia, and Brazil,
where dengue has been epidemic for several years, the mean
age of dengue infection is increasing and adults are frequently
infected, indicating an epidemiologic change in dengue infec-
tion in those locations (1,10).
The precise magnitude of this countrywide outbreak is
unknown; 5,575 hospitalized dengue cases were reported to
the Ministry of Health in Bangladesh, with a case-fatality rate
of 1.61% through mid-November 2000 (6). Most patients had
DF, 25% with bleeding manifestations (a severe form of the
illness) (1,4). WHO classification of dengue diseases is often
not feasible in many countries because of lack of trained health
professionals, adequate laboratories, and radiologic support.
The facilities to detect DHF by using hematocrit (capillary
method) and plasma leakage signs (chest radiograph or ultra-
sound) are not readily available in many tropical countries.
Successful treatment of dengue depends on symptom recogni-
tion and careful fluid management (1). Thus, a simple classifi-
cation scheme of dengue diseases based on symptoms and
signs is needed to improve case management and reduce
deaths.
DHF is believed to occur as a result of antibody-dependent
enhancement of heterotypic-secondary dengue infections
(1,4,11). Our findings support the role of sequential infection
in the development of DHF. However, occurrence of DHF in
some patients with primary infection suggests additional host
and virologic factors. 
In our study, DSS was a rare event, resulting in a lower
case-fatality rate for dengue than reported elsewhere (7), likely
representing hospitalization of less severe cases. We have
insufficient data to comment on the virulence of the outbreak
strain. High numbers of Ae. aegypti were identified throughout
the city (Y. Wagatsuma, ICDDR,B; pers. comm.). Insecticide
spraying, public health education (including community
source reduction), and perhaps most importantly, the onset of
the dry winter season may have contributed to ending this den-
gue outbreak in 2000.
Therapeutic strategies proposed by WHO have been
widely circulated by the Bangladesh government, and physi-
cians continue to gain experience in proper management of
dengue. Ongoing surveillance, vector surveys, and epidemio-
logic studies to identify risk factors will provide key informa-
tion for controlling dengue. Ultimately, a safe and effective
vaccine will be needed to address this emerging problem in
Bangladesh and elsewhere.
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